Definium Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Definium Therapeutics Operating Expenses Growth & History (DFTX)
Definium Therapeutics's operating expenses was $166.3M for fiscal 2025.
View full Definium Therapeutics company overviewDefinium Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $166.3M | $62.4M | +60.04% |
| 2024 | 2024-12-31 | $103.9M | $10.1M | +10.71% |
| 2023 | 2023-12-31 | $93.9M | $27.5M | +41.51% |
| 2022 | 2022-12-31 | $66.3M | −$27.5M | −29.33% |
| 2021 | 2021-12-31 | $93.9M | $60.8M | +184.15% |
| 2020 | 2020-12-31 | $33.0M | — | — |
Definium Therapeutics quarterly operating expenses
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $75.1M | $34.2M | +83.55% |
| Q1 2026 | 2026-03-31 | $59.2M | $27.1M | +84.15% |
| Q4 2025 | 2025-12-31 | $47.6M | $15.1M | +46.57% |
| Q3 2025 | 2025-09-30 | $45.7M | $20.9M | +84.21% |
| Q2 2025 | 2025-06-30 | $40.9M | $16.4M | +67.24% |
| Q1 2025 | 2025-03-31 | $32.2M | $10.0M | +44.83% |
| Q4 2024 | 2024-12-31 | $32.5M | $10.3M | +46.20% |
| Q3 2024 | 2024-09-30 | $24.8M | $3.2M | +14.69% |
| Q2 2024 | 2024-06-30 | $24.5M | −$4.7M | −16.19% |
| Q1 2024 | 2024-03-31 | $22.2M | $1.3M | +6.43% |
| Q4 2023 | 2023-12-31 | $22.2M | $8.3M | +59.74% |
| Q3 2023 | 2023-09-30 | $21.6M | $4.6M | +27.28% |
| Q2 2023 | 2023-06-30 | $29.2M | $12.2M | +72.25% |
| Q1 2023 | 2023-03-31 | $20.9M | $2.4M | +12.74% |
| Q4 2022 | 2022-12-31 | $13.9M | −$3.7M | −20.84% |
| Q3 2022 | 2022-09-30 | $17.0M | −$244,000 | −1.42% |
| Q2 2022 | 2022-06-30 | $16.9M | −$28.3M | −62.53% |
| Q1 2022 | 2022-03-31 | $18.5M | $4.7M | +33.63% |
| Q4 2021 | 2021-12-31 | $17.6M | — | — |
| Q3 2021 | 2021-09-30 | $17.2M | — | — |
| Q2 2021 | 2021-06-30 | $45.2M | — | — |
| Q1 2021 | 2021-03-31 | $13.8M | — | — |
Definium Therapeutics operating expenses trends
Over the last five fiscal years, Definium Therapeutics's operating expenses increased from $33.0M to $166.3M, a change of $133.3M. The latest reported quarter, Q2 2026, shows $75.1M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Definium Therapeutics source filings ↗